NewsBenzingaGoldman Sachs reanuda la calificación neutral en Kodiak Sciences y anuncia un precio objetivo de $36 Goldman Sachs reanuda la calificación neutral en Kodiak Sciences y anuncia un precio objetivo de $36 Benzinga 2026.09.24 11:31 (GMT+0) Open on Benzinga Other news Google, OpenAI and Anthropic's AI safety organization is taking shape AJ Scaramucci's Solari Capital emerges from stealth, deploying about $350 million into AI and other sectors Oracle’s stock is falling as investors fear a data-center setback Atlassian: A $140 Billion Market Growing At 14% Annually Creates A Massive Opportunity Australia to investigate if OpenAI hack of government health website broke the law Is Jack Henry & Associates Stock Underperforming the Dow?
AJ Scaramucci's Solari Capital emerges from stealth, deploying about $350 million into AI and other sectors
